Home / Drug shortages / Tiagabine Hydrochloride Tablet

Tiagabine Hydrochloride Tablet — FDA Drug Shortage

To Be Discontinued — Teva Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Tiagabine Hydrochloride Tablet (tablet) from Teva Pharmaceuticals USA, Inc. with status To Be Discontinued. The shortage was first posted on 04/15/2026.

Shortage Details

Status
To Be Discontinued
Company
Teva Pharmaceuticals USA, Inc.
Package NDC
0093-5030-56
Dosage Form
Tablet
Presentation
Tiagabine Hydrochloride, Tablet, 2mg 30 count (NDC 0093-5030-56)
Initial Posting
04/15/2026
Revised Date

FDA data resources